Genomma Lab Internacional, S.A.B. de C.V. GNMLF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 38.48% | -23.43% | 57.88% | -23.53% | 28.07% |
| Total Depreciation and Amortization | 0.08% | 0.77% | -0.37% | 1.24% | 8.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.61% | 50.57% | -25.05% | 521.76% | -80.37% |
| Change in Net Operating Assets | 8.62% | 58.21% | -325.02% | 446.48% | 33.45% |
| Cash from Operations | 30.27% | 269.09% | -119.00% | 190.14% | -9.49% |
| Capital Expenditure | 79.23% | -5.43% | 46.57% | -74.91% | -58.12% |
| Sale of Property, Plant, and Equipment | -145.87% | 5,158.38% | -86.58% | 6,503.13% | -95.76% |
| Cash Acquisitions | 78.27% | -1,175.30% | 97.01% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.10% | 114.66% | 270.48% | -7.71% | -124.14% |
| Cash from Investing | -182.03% | 179.67% | 88.48% | -138.82% | -75.15% |
| Total Debt Issued | 281.24% | -46.92% | 87.67% | -45.02% | -52.11% |
| Total Debt Repaid | -136.30% | -32.32% | -59.93% | 55.98% | 52.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -370.47% | 82.35% | 98.55% | -6,250.73% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.56% | -0.95% | -4.13% | 49.17% | -- |
| Other Financing Activities | 26.22% | -0.20% | 9.15% | -1.08% | 2.67% |
| Cash from Financing | 78.52% | -863.84% | 148.26% | 57.14% | -439.82% |
| Foreign Exchange rate Adjustments | -95.25% | 182.89% | 28.44% | -4.00% | 45.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 249.53% | 3.05% | -139.98% | 341.46% | -161.18% |